149 related articles for article (PubMed ID: 20166925)
1. Cannabinoid CB(2) receptors in health and disease.
Patel KD; Davison JS; Pittman QJ; Sharkey KA
Curr Med Chem; 2010; 17(14):1393-410. PubMed ID: 20166925
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids and intestinal motility: welcome to CB2 receptors.
Izzo AA
Br J Pharmacol; 2004 Aug; 142(8):1201-2. PubMed ID: 15277313
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.
Wright KL; Duncan M; Sharkey KA
Br J Pharmacol; 2008 Jan; 153(2):263-70. PubMed ID: 17906675
[TBL] [Abstract][Full Text] [Related]
4. The cannabinoid CB(2) receptor: a good friend in the gut.
Izzo AA
Neurogastroenterol Motil; 2007 Sep; 19(9):704-8. PubMed ID: 17727390
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids in the gastrointestinal tract.
Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
[TBL] [Abstract][Full Text] [Related]
6. CB2: a cannabinoid receptor with an identity crisis.
Atwood BK; Mackie K
Br J Pharmacol; 2010 Jun; 160(3):467-79. PubMed ID: 20590558
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system and gut-brain signalling.
Storr MA; Sharkey KA
Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
[TBL] [Abstract][Full Text] [Related]
8. At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction.
Montecucco F; Di Marzo V
Trends Pharmacol Sci; 2012 Jun; 33(6):331-40. PubMed ID: 22503477
[TBL] [Abstract][Full Text] [Related]
9. Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher P; Mechoulam R
Prog Lipid Res; 2011 Apr; 50(2):193-211. PubMed ID: 21295074
[TBL] [Abstract][Full Text] [Related]
10. The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
Moris D; Georgopoulos S; Felekouras E; Patsouris E; Theocharis S
Expert Opin Ther Targets; 2015; 19(9):1261-75. PubMed ID: 25936364
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.
Rom S; Persidsky Y
J Neuroimmune Pharmacol; 2013 Jun; 8(3):608-20. PubMed ID: 23471521
[TBL] [Abstract][Full Text] [Related]
12. Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.
Yang P; Wang L; Xie XQ
Future Med Chem; 2012 Feb; 4(2):187-204. PubMed ID: 22300098
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid system and immune modulation.
Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of cannabinoid receptor ligands: current status.
Singh J; Budhiraja S
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.
Curto-Reyes V; Boto T; Hidalgo A; Menéndez L; Baamonde A
Eur J Pharmacol; 2011 Oct; 668(1-2):184-9. PubMed ID: 21771590
[TBL] [Abstract][Full Text] [Related]
19. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
[TBL] [Abstract][Full Text] [Related]
20. Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.
Steffens S; Pacher P
Br J Pharmacol; 2012 Sep; 167(2):313-23. PubMed ID: 22612332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
